
### [NCIT:C96166](http://purl.obolibrary.org/obo/NCIT_C96166)
**Label:** Digestive System Neuroendocrine Tumor G2

**Subclasses:** [NCIT:C96163](http://purl.obolibrary.org/obo/NCIT_C96163) (Colorectal Neuroendocrine Tumor G2), [NCIT:C96165](http://purl.obolibrary.org/obo/NCIT_C96165) (Intestinal Neuroendocrine Tumor G2), [NCIT:C96067](http://purl.obolibrary.org/obo/NCIT_C96067) (Small Intestinal Neuroendocrine Tumor G2), [NCIT:C27466](http://purl.obolibrary.org/obo/NCIT_C27466) (Pancreatic ACTH-Producing Neuroendocrine Tumor), [NCIT:C96423](http://purl.obolibrary.org/obo/NCIT_C96423) (Appendix Neuroendocrine Tumor G2), [NCIT:C95983](http://purl.obolibrary.org/obo/NCIT_C95983) (Ampulla of Vater Neuroendocrine Tumor G2), [NCIT:C45841](http://purl.obolibrary.org/obo/NCIT_C45841) (Functional Pancreatic Neuroendocrine Tumor G2), [NCIT:C95880](http://purl.obolibrary.org/obo/NCIT_C95880) (Gastric Neuroendocrine Tumor G2), [NCIT:C95617](http://purl.obolibrary.org/obo/NCIT_C95617) (Esophageal Neuroendocrine Tumor G2), [NCIT:C45835](http://purl.obolibrary.org/obo/NCIT_C45835) (Pancreatic Neuroendocrine Tumor G2), [NCIT:C67369](http://purl.obolibrary.org/obo/NCIT_C67369) (Malignant Pancreatic Somatostatinoma), [NCIT:C45838](http://purl.obolibrary.org/obo/NCIT_C45838) (Non-Functional Pancreatic Neuroendocrine Tumor G2), [NCIT:C65187](http://purl.obolibrary.org/obo/NCIT_C65187) (Malignant Pancreatic Glucagonoma), [NCIT:C96546](http://purl.obolibrary.org/obo/NCIT_C96546) (Anal Canal Neuroendocrine Tumor G2), [NCIT:C96957](http://purl.obolibrary.org/obo/NCIT_C96957) (Extrahepatic Bile Duct Neuroendocrine Tumor G2), [NCIT:C96925](http://purl.obolibrary.org/obo/NCIT_C96925) (Gallbladder Neuroendocrine Tumor G2), 

**Class expressions from DL-Learner:**

- [NCIT:C36141](http://purl.obolibrary.org/obo/NCIT_C36141) (Intermediate Grade Lesion) 62.50%
- [NCIT:C36133](http://purl.obolibrary.org/obo/NCIT_C36133) (Well Differentiated Lesion) 62.50%
- [NCIT:C36132](http://purl.obolibrary.org/obo/NCIT_C36132) (Poorly Differentiated Lesion) 62.50%
- [NCIT:C28078](http://purl.obolibrary.org/obo/NCIT_C28078) (Grade 2) 62.50%
- Thing 51.30%
- [NCIT:C3824](http://purl.obolibrary.org/obo/NCIT_C3824) (Lesion) 48.33%
- [NCIT:C42078](http://purl.obolibrary.org/obo/NCIT_C42078) (Lesion by Morphology) 44.61%
- [NCIT:C83490](http://purl.obolibrary.org/obo/NCIT_C83490) (Microscopic Finding) 41.77%
- [NCIT:C3367](http://purl.obolibrary.org/obo/NCIT_C3367) (Finding) 40.58%
- [NCIT:C7057](http://purl.obolibrary.org/obo/NCIT_C7057) (Disease, Disorder or Finding) 39.85%
- [NCIT:C36298](http://purl.obolibrary.org/obo/NCIT_C36298) (Lesion by Grade) 37.50%
- [NCIT:C28099](http://purl.obolibrary.org/obo/NCIT_C28099) (Disease Morphology Qualifier) 32.91%
- [NCIT:C28076](http://purl.obolibrary.org/obo/NCIT_C28076) (Disease Grade Qualifier) 32.91%
- [NCIT:C41009](http://purl.obolibrary.org/obo/NCIT_C41009) (Qualifier) 24.29%
- [NCIT:C27992](http://purl.obolibrary.org/obo/NCIT_C27992) (Disease Qualifier) 24.29%


